CDC Picks Thimerosal Researcher for Vaccines, Autism Study
On Mar. 7, 2025, the Associated Press and other media sources reported that the U.S. Centers for Disease Control and Prevention (CDC) is planning to conduct a study to determine possible links between vaccines and autism. In a prepared statement, the DHHS vaccine policymaking agency said that the “CDC will leave no stone unturned in its […]
NIH Cuts Funding for “Vaccine Hesitancy” Research
Certain areas of research funded by the U.S. National Institutes of Health (NIH) is being reduced or discontinued with the justification that these areas no longer align with the agency’s current priorities. One of the areas in which funding will be cut is millions of dollars in NIH grants for studying vaccine hesitancy and strategies […]
CDC Plans to Conduct Study on Reported Link Between Vaccines and Autism
The U.S. Centers for Disease Control and Prevention (CDC) is planning to conduct a study to explore persistent reports that there is a link between vaccines and autism, according to a Mar. 7, 2025 report first published by Reuters1 and followed by The Washington Post on Mar. 7, 2025.2 A Department of Health and Human Services […]
DHHS Secretary RFK, Jr. and USDA Secretary Both Say “No” to Bird Flu Vaccine for Chickens
Opinion | Secretary of Health and Human Services Robert F. Kennedy, Jr announced on Mar. 4, 2025 that the avian influenza (“bird flu”) vaccine should not be given to chickens in the U.S. based on emerging evidence that injecting poultry with avian influenza virus (AIV) vaccine could lead to mutations accelerating evolution of the animal […]
USDA Gives Conditional License for Bird Flu Vaccine Given to Chickens
The U.S. Department of Agriculture (USDA) has issued a conditional license approval for an inactivated avian flu (bird flu) vaccine to be administered to chickens eaten by Americans. The license is being granted due to H5N1 influenza virus infections spreading in U.S. poultry. The United States has avoided giving H5N1 vaccine to until now. The […]
FDA Approves GSK’s 5-in-1 Meningococcal Vaccine
On Feb. 14, 2025, British pharmaceutical and biotechnology company GSK plc announced that the U.S. Food and Drug Administration (FDA) approved its 5-in-1 meningococcal vaccine PENMENVY for licensure and use in individuals aged 10 through 25 years. The vaccine targets five major serogroups of the bacterium Neisseria meningitidis (A, B, C, W, and Y), which […]